AZ.PHARMABEL: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
AZ.PHARMABEL
Largest movements
- Receivables within one year +€33,944
up €33,944 (+33.0%), from €102,802 to €136,746
of which Trade receivables: +€45,154
- Tangible fixed assets +€23,864
up €23,864 (+132.4%), from €18,024 to €41,888
of which Other tangible fixed assets: +€22,018
- Cash -€21,097
down €21,097 (-15.2%), from €138,575 to €117,478
mainly Trade debts (-€82,244) and Receivables within one year (-€33,944)
- Stocks and contracts -€11,870
down €11,870 (-36.6%), from €32,400 to €20,530
- Debts after one year +€96,000
new in 2025: €96,000
- Trade debts -€82,244
down €82,244 (-24.4%), from €337,551 to €255,307
- Profit (loss) carried forward +€8,418
up €8,418 (+11.7%), from €71,863 to €80,281
- Staff costs +€31,291
up €31,291 (+173.7%), from €18,013 to €49,304
- Gross operating margin -€25,923
down €25,923 (-27.2%), from €95,362 to €69,439
- Turnover -€17,115
down €17,115 (-1.7%), from €983,777 to €966,662
- Taxes -€16,041
down €16,041 (-80.7%), from €19,877 to €3,836
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €457,472 | €479,564 | +€22,092 | +4.8% |
| Fixed assets | 21/28 | €171,963 | €195,827 | +€23,864 | +13.9% |
| Intangible fixed assets | 21 | €0 | €0 | = | |
| Tangible fixed assets | 22/27 | €18,024 | €41,888 | +€23,864 | +132.4% |
| Plant, machinery and equipment | 23 | €127 | - | -€127 | |
| Furniture and vehicles | 24 | €8,850 | €10,823 | +€1,973 | +22.3% |
| Other tangible fixed assets | 26 | €9,047 | €31,065 | +€22,018 | +243.4% |
| Financial fixed assets | 28 | €153,939 | €153,939 | = | 0.0% |
| Current assets | 29/58 | €285,509 | €283,737 | -€1,772 | -0.6% |
| Amounts receivable after more than one year | 29 | €8,982 | €8,983 | +€1 | 0.0% |
| Trade receivables | 290 | €8,982 | €8,983 | +€1 | 0.0% |
| Stocks and contracts in progress | 3 | €32,400 | €20,530 | -€11,870 | -36.6% |
| Stocks | 30/36 | €32,400 | €20,530 | -€11,870 | -36.6% |
| Amounts receivable within one year | 40/41 | €102,802 | €136,746 | +€33,944 | +33.0% |
| Trade receivables | 40 | €22,916 | €68,070 | +€45,154 | +197.0% |
| Other amounts receivable | 41 | €79,886 | €68,676 | -€11,210 | -14.0% |
| Cash at bank and in hand | 54/58 | €138,575 | €117,478 | -€21,097 | -15.2% |
| Deferred charges and accrued income | 490/1 | €2,750 | - | -€2,750 | |
| Total equity and liabilities | 10/49 | €457,472 | €479,564 | +€22,092 | +4.8% |
| Equity | 10/15 | €92,323 | €100,741 | +€8,418 | +9.1% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Capital | 10 | €18,600 | €18,600 | = | 0.0% |
| Issued capital | 100 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Legal reserve | 130 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | €71,863 | €80,281 | +€8,418 | +11.7% |
| Amounts payable | 17/49 | €365,149 | €378,823 | +€13,674 | +3.7% |
| Amounts payable after more than one year | 17 | - | €96,000 | +€96,000 | |
| Financial debts | 170/4 | - | €96,000 | +€96,000 | |
| Amounts payable within one year | 42/48 | €362,402 | €277,323 | -€85,079 | -23.5% |
| Current portion of amounts payable after more than one year | 42 | €0 | - | = | |
| Trade debts | 44 | €337,551 | €255,307 | -€82,244 | -24.4% |
| Suppliers | 440/4 | €337,551 | €255,307 | -€82,244 | -24.4% |
| Taxes, remuneration and social security | 45 | €24,851 | €22,016 | -€2,835 | -11.4% |
| Taxes | 450/3 | €23,682 | €9,208 | -€14,474 | -61.1% |
| Remuneration and social security | 454/9 | €1,169 | €12,808 | +€11,639 | +995.6% |
| Accrued charges and deferred income | 492/3 | €2,747 | €5,500 | +€2,753 | +100.2% |
| Turnover | 70 | €983,777 | €966,662 | -€17,115 | -1.7% |
| Goods, raw materials, services and sundry goods | 60/61 | €888,416 | €897,223 | +€8,807 | +1.0% |
| Remuneration, social security and pensions | 62 | €18,013 | €49,304 | +€31,291 | +173.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €8,780 | €5,681 | -€3,099 | -35.3% |
| Other operating charges | 640/8 | €932 | €1,030 | +€98 | +10.5% |
| Gross operating margin | 9900 | €95,362 | €69,439 | -€25,923 | -27.2% |
| Operating profit (loss) | 9901 | €67,637 | €13,424 | -€54,213 | -80.2% |
| Financial income | 75/76B | €66 | €131 | +€65 | +98.5% |
| Recurring financial income | 75 | €66 | €131 | +€65 | +98.5% |
| Financial charges | 65/66B | €1,410 | €1,301 | -€109 | -7.7% |
| Recurring financial charges | 65 | €1,410 | €1,301 | -€109 | -7.7% |
| Profit (loss) for the period before taxes | 9903 | €66,293 | €12,254 | -€54,039 | -81.5% |
| Income taxes | 67/77 | €19,877 | €3,836 | -€16,041 | -80.7% |
| Profit (loss) for the period | 9904 | €46,416 | €8,418 | -€37,998 | -81.9% |
| Profit (loss) for the period to be appropriated | 9905 | €46,416 | €8,418 | -€37,998 | -81.9% |
Source: filed annual accounts (NBB), fiscal years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.